Magenta conditioning lead clinical candidate mgta-117 demonstrates broad tolerability and high therapeutic index in non-human primates

Magenta conditioning lead clinical candidate mgta-117 demonstrates broad tolerability and high therapeutic index in non-human primates.magenta therapeutics inc - magenta plans to move mgta-117 into clinic with initial clinical data in 2021.magenta therapeutics inc - mgta-117 demonstrated robust anti-tumor activity in xenograft models from patients with refractory leukemia.magenta therapeutics - mgta-117 adc clinical candidate for conditioning showed broad tolerability and wide pre-clinical safety margins.magenta therapeutics - scaling up manufacturing of mgta-117 and completing ind-enabling studies in 2020.
DNTH Ratings Summary
DNTH Quant Ranking